While this study provides valuable insights into the molecular dynamics of circadian clock genes in astrocytic tumors, several limitations must also be acknowledged, including the relatively small sample size, the lack of functional validation, and the need for more advanced methylation analysis techniques. This evidence concerns the gene CLOCK and astrocytic tumor.